R&D 4 years on: Remembering the COVID-19 pandemic This year, Monday 11th March marked four years since the World Health Organization (WHO) declared COVID-19 a global pandemic.
Views & Analysis The unprecedented challenge of pricing a coronavirus vaccine The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that enables the eligible population in need across the world to gain access, while also rewardi
News EC clears first treatment for high-risk smouldering multiple... Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
